Brooktree Capital Management Covetrus, Inc. Transaction History

Brooktree Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$13.8 - $20.82 $2.63 Million - $3.96 Million	-190,339 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$15.96 - $18.87 $1.93 Million - $2.28 Million	120,847 Added 173.9%	190,339 $3.2 Million
Q4 2021 Feb 07, 2022	SELL	$16.79 - $20.37 $21,407 - $25,971	-1,275 Reduced 1.8%	69,492 $1.39 Million
Q4 2020 Feb 03, 2021	SELL	$24.45 - $31.59 $58,044 - $74,994	-2,374 Reduced 3.25%	70,767 $2.03 Million
Q3 2020 Nov 09, 2020	BUY	$17.22 - $24.59 $124,070 - $177,170	7,205 Added 10.93%	73,141 $1.78 Million
Q2 2020 Aug 03, 2020	BUY	$6.46 - $19.27 $37,338 - $111,380	5,780 Added 9.61%	65,936 $1.18 Million
Q1 2020 May 06, 2020	BUY	$5.64 - $15.23 $339,279 - $916,175	60,156 New	60,156 $490,000

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Brooktree Capital Management, based on Form 13F filings with the SEC.

Stay updated on Brooktree Capital Management with notifications on news.